Stock data
永笙-KY (4178)
永笙-KY is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$30.71M, up 28.2% from a year earlier. EPS over the last four quarters totals -NT$0.91.
Company profile
Data as of 2026-10-18
- Market
- TWSE-listed
- Industry
- Biotech & Medical Care
- Listed
- 2026-04-30
- Founded
- 2013-06-26
- Paid-in capital
- NT$2.16B
- Common shares issued
- 215,905,315
- Legal name
- 永笙生技股份有限公司
- Website
- https://stemcytebio.com/
Monthly revenue
Data as of 2026-10-17
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$30.71M | -3.9% | +28.2% |
| 2026-08 | NT$31.97M | -1.4% | +9.0% |
Year to date: +2.7% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | -0.25 |
| 2026 Q1 | -0.19 |
| 2025 Q4 | -0.25 |
| 2025 Q3 | -0.22 |
Last four quarters: -NT$0.91
Dividends
Data as of 2026-10-18
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 0.00 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 295 | 0.0% |
| 1,000–5,000 shares | 2,747 | 2.2% |
| 5,001–10,000 shares | 357 | 1.4% |
| 10,001–15,000 shares | 136 | 0.8% |
| 15,001–20,000 shares | 112 | 1.0% |
| 20,001–30,000 shares | 120 | 1.4% |
| 30,001–40,000 shares | 73 | 1.2% |
| 40,001–50,000 shares | 48 | 1.1% |
| 50,001–100,000 shares | 91 | 3.1% |
| 100,001–200,000 shares | 73 | 5.0% |
| 200,001–400,000 shares | 42 | 5.3% |
| 400,001–600,000 shares | 9 | 2.1% |
| 600,001–800,000 shares | 8 | 2.6% |
| 800,001–1,000,000 shares | 1 | 0.4% |
| 1,000,001+ shares | 26 | 72.4% |
TDCC data for 2026-10-16: 26 holders own more than 1,000 lots (72.4% of shares), and 295 hold less than one lot (0.0%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | -21 | 0 | 0 | -21 |
| 2026-10-16 | 15 | 0 | 0 | 15 |
| 2026-10-15 | 20 | 0 | 5 | 25 |
| 2026-10-14 | -41 | 0 | -2 | -43 |
| 2026-10-13 | -21 | 0 | -2 | -23 |
| 2026-10-12 | -90 | 0 | 4 | -86 |
| 2026-10-08 | 264 | 0 | -4 | 260 |
| 2026-10-07 | 27 | 0 | 3 | 30 |
| 2026-10-06 | -7 | 0 | 1 | -6 |
| 2026-10-05 | -23 | 0 | -1 | -24 |
| 2026-10-02 | -88 | 0 | -3 | -91 |
| 2026-10-01 | 79 | 0 | 2 | 81 |
| 2026-09-30 | 21 | 0 | 0 | 21 |
| 2026-09-29 | 7 | 0 | 1 | 8 |
| 2026-09-24 | -10 | 0 | -3 | -13 |
| 2026-09-23 | -1 | 0 | 2 | 1 |
| 2026-09-22 | 4 | 0 | -1 | 3 |
| 2026-09-21 | -4 | 0 | 2 | -2 |
| 2026-09-18 | 25 | 0 | 3 | 28 |
| 2026-09-17 | 14 | 0 | 2 | 16 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 179 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$17.20 (2026-10-19).
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.